東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Revising oral pharmacokinetics, bioa...

Macheras, P.

FindBook

Google Book

Amazon

博客來

Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept/ by Panos Macheras, Athanasios A. Tsekouras.
作者:	Macheras, P.
其他作者:	Tsekouras, Athanasios A.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	xv, 129 p. :ill., digital ;24 cm.
內容註:	Part I: Oral Pharmacokinetics -- Chapter 1. From Bateman (1908) To Dost (1953) -- Chapter 2. The Unphysical Hypothesis Of Infinite Absorption Time -- Chapter 3. The Finite Absorption Time (Fat) Concept -- Chapter 4. The Rise Of Physiologically Based Finite Time Pharmacokinetic (Pbftpk) Models -- Part II: Bioavailability-Bioequivalence -- Chapter 5. History Of The Bioavailability-Bioequivalence Concepts -- Chapter 6. Therapeutic Equivalence Based On Bioequivalence Studies -- Chapter 7. Bioavailability Under The Prism Of Finite Absorption Time -- Chapter 8. Bioequivalence Under The Prism Of Finite Absorption Time.
Contained By:	Springer Nature eBook
標題:	Pharmacokinetics. -
電子資源:	https://doi.org/10.1007/978-3-031-20025-0
ISBN:	9783031200250

Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept
Macheras, P.

Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept[electronic resource] /by Panos Macheras, Athanasios A. Tsekouras. - Cham :Springer International Publishing :2023. - xv, 129 p. :ill., digital ;24 cm.

Part I: Oral Pharmacokinetics -- Chapter 1. From Bateman (1908) To Dost (1953) -- Chapter 2. The Unphysical Hypothesis Of Infinite Absorption Time -- Chapter 3. The Finite Absorption Time (Fat) Concept -- Chapter 4. The Rise Of Physiologically Based Finite Time Pharmacokinetic (Pbftpk) Models -- Part II: Bioavailability-Bioequivalence -- Chapter 5. History Of The Bioavailability-Bioequivalence Concepts -- Chapter 6. Therapeutic Equivalence Based On Bioequivalence Studies -- Chapter 7. Bioavailability Under The Prism Of Finite Absorption Time -- Chapter 8. Bioequivalence Under The Prism Of Finite Absorption Time.

This book casts new light on the field of oral drug absorption. It outlines both the concept of the past and the novel concept of Finite Absorption Time (FAT) In addition, the authors explore the correlated need for re-definition of bioavailability, bioequivalence providing a plethora of experimental data. Accordingly, this book is intended for academics/students or scientists working in pharmaceutical industries, regulatory agencies, and contract research organizations. It can be used for teaching purposes in under- and post-graduate courses dealing with biopharmaceutics, pharmacokinetics and biomedical engineering. This excellent text serves as a historical review of drug absorption kinetics and its application to bioavailability and bioequivalence. However, its main thrust is the application of the authors' innovative new approaches to modifying these processes utilizing concepts of finite absorption time (FAT) and physiologically based finite time pharmacokinetic (PBFTPK) models. The work described in detail is based on the innovative experimental studies, many in depth examples and simulations, and the authors' outstanding theoretical contributions to our understanding of drug gastrointestinal absorption, and drug pharmacokinetics. I found the book to be an enjoyable and enlightening read. Professor Leslie Benet, Department of Bioengineering & Therapeutic Sciences, Schools of Pharmacy & Medicine, University of California, San Francisco, USA.

ISBN: 9783031200250

Standard No.: 10.1007/978-3-031-20025-0doiSubjects--Topical Terms:

550960
Pharmacokinetics.

LC Class. No.: RM301.5 / .M33 2023

Dewey Class. No.: 615.7

Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept
LDR:03153nmm a2200325 a 4500 001 2313986
003 DE-He213
005 20221221230648.0
006 m d
007 cr nn 008mamaa
008 230902s2023 sz s 0 eng d
020 $a 9783031200250 $q (electronic bk.)
020 $a 9783031200243 $q (paper)
024 7 $a 10.1007/978-3-031-20025-0 $2 doi
035 $a 978-3-031-20025-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.5 $b .M33 2023
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.7 $2 23
090 $a RM301.5 $b .M149 2023
100 1 $a Macheras, P. $3 3625116
245 1 0 $a Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept $h [electronic resource] / $c by Panos Macheras, Athanasios A. Tsekouras.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xv, 129 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part I: Oral Pharmacokinetics -- Chapter 1. From Bateman (1908) To Dost (1953) -- Chapter 2. The Unphysical Hypothesis Of Infinite Absorption Time -- Chapter 3. The Finite Absorption Time (Fat) Concept -- Chapter 4. The Rise Of Physiologically Based Finite Time Pharmacokinetic (Pbftpk) Models -- Part II: Bioavailability-Bioequivalence -- Chapter 5. History Of The Bioavailability-Bioequivalence Concepts -- Chapter 6. Therapeutic Equivalence Based On Bioequivalence Studies -- Chapter 7. Bioavailability Under The Prism Of Finite Absorption Time -- Chapter 8. Bioequivalence Under The Prism Of Finite Absorption Time.
520 $a This book casts new light on the field of oral drug absorption. It outlines both the concept of the past and the novel concept of Finite Absorption Time (FAT) In addition, the authors explore the correlated need for re-definition of bioavailability, bioequivalence providing a plethora of experimental data. Accordingly, this book is intended for academics/students or scientists working in pharmaceutical industries, regulatory agencies, and contract research organizations. It can be used for teaching purposes in under- and post-graduate courses dealing with biopharmaceutics, pharmacokinetics and biomedical engineering. This excellent text serves as a historical review of drug absorption kinetics and its application to bioavailability and bioequivalence. However, its main thrust is the application of the authors' innovative new approaches to modifying these processes utilizing concepts of finite absorption time (FAT) and physiologically based finite time pharmacokinetic (PBFTPK) models. The work described in detail is based on the innovative experimental studies, many in depth examples and simulations, and the authors' outstanding theoretical contributions to our understanding of drug gastrointestinal absorption, and drug pharmacokinetics. I found the book to be an enjoyable and enlightening read. Professor Leslie Benet, Department of Bioengineering & Therapeutic Sciences, Schools of Pharmacy & Medicine, University of California, San Francisco, USA.
650 0 $a Pharmacokinetics. $3 550960
650 0 $a Drugs $x Bioavailability. $3 738670
650 0 $a Oral medication. $3 916362
650 0 $a Drugs $x Absorption and adsorption. $3 3625118
650 1 4 $a Pharmaceutics. $3 3538434
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Pharmacy. $3 636101
650 2 4 $a Biomedical Engineering and Bioengineering. $3 3381533
700 1 $a Tsekouras, Athanasios A. $3 3625117
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-20025-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)